Maternal Immunization Vaccine Study at CCfV
IWK researchers want to protect kids from certain infections before they’re born
Dr. Lisa Barrett Leading PEI Inmate Study
Click here to read the CBC news piece on Dr. Lisa Barrett’s research study!
2016 Weaver Tremblay Award Winner Dr. Janice Graham
Congratulations to Dr. Janice Graham, who has been chosen for the Weaver-Tremblay Award in Canadian Applied Anthropology in 2016. The Weaver-Tremblay Award is the top honour for Anthropology in Canada. Read More…
CCfV/CIRN Research Education Series Fall/Winter Presentation Schedule
This series, jointly organized by the Canadian Immunization Research Network (CIRN) and the Canadian Center for Vaccinology (CCfV), includes one or two presentations each month, available by webinar.
Immunovaccine Initiates Clinical Trial with DPX-RSV Vaccine
Halifax, Nova Scotia; June 30, 2015 – Immunovaccine Inc. , a clinical stage vaccine and immunotherapy company, today announced that it has enrolled the first healthy adult volunteer in a Phase 1 clinical study of its respiratory syncytial virus (RSV) vaccine.
The Phase 1 study will evaluate the safety and immune response profile of the DPX-RSV vaccine candidate in healthy adults. The study, conducted at the Canadian Center for Vaccinology (CCfV) in Halifax and led by Joanne Langley, M.D., will enroll 40 healthy adults who are 50 to 64 years of age. Read More…